APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics

Achariyar, 2016, Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation., Mol. Neurodegener., 11, 1, 10.1186/s13024-016-0138-8

Aizenstein, 2008, Frequent amyloid deposition without significant cognitive impairment among the elderly., Arch. Neurol., 65, 1509, 10.1001/archneur.65.11.1509

Altmann, 2014, Sex modifies the APOE-related risk of developing Alzheimer disease., Ann. Neurol., 75, 563, 10.1002/ana.24135

Ancelin, 2014, Gender-specific associations between lipids and cognitive decline in the elderly., Eur. Neuropsychopharmacol., 24, 1056, 10.1016/j.euroneuro.2014.02.003

Arenaza-Urquijo, 2019, The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies., Brain, 142, 1134, 10.1093/brain/awz037

Baker-Nigh, 2016, Human central nervous system (CNS) ApoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared with plasma., J. Biol. Chem., 291, 27204, 10.1074/jbc.m116.721779

Barnes, 2005, Sex differences in the clinical manifestations of Alzheimer disease pathology., Arch. Gen. Psychiatry, 62, 685, 10.1001/archpsyc.62.6.685

Belloy, 2019, A quarter century of APOE and Alzheimer’s disease: progress to date and the path forward., Neuron, 101, 820, 10.1016/j.neuron.2019.01.056

Boehm-Cagan, 2016, ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies., J. Alzheimers Dis., 54, 1219, 10.3233/jad-160467

Boisvert, 2018, The aging astrocyte transcriptome from multiple regions of the mouse brain., Cell Rep., 22, 269, 10.1016/j.celrep.2017.12.039

Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors., J. Biol. Chem., 286, 17217, 10.1074/jbc.m110.217380

Bu, 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy., Nat. Rev. Neurosci., 10, 333, 10.1038/nrn2620

Cam, 2006, Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family., Mol. Neurodegener., 1, 1, 10.1186/1750-1326-1-8

Cam, 2004, The low density lipoprotein receptor-related protein 1B retains β-amyloid precursor protein at the cell surface and reduces amyloid-β peptide production., J. Biol. Chem., 279, 29639, 10.1074/jbc.m313893200

Cao, 2017, ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury., Sci. Rep., 7, 1, 10.1038/s41598-017-11654-7

Castellano, 2011, Human apoE isoforms differentially regulate brain amyloid-β peptide clearance., Sci. Transl. Med., 3, 10.1126/scitranslmed.3002156

Cesa, 2015, Direct and propagated effects of small molecules on protein–protein interaction networks., Front. Bioeng. Biotechnol., 3, 10.3389/fbioe.2015.00119

Chen, 2010, ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling., Proc. Natl. Acad. Sci. U.S.A., 107, 12011, 10.1073/pnas.0914984107

Chernick, 2019, Peripheral versus central nervous system APOE in Alzheimer’s disease: interplay across the blood-brain barrier., Neurosci. Lett., 708, 10.1016/j.neulet.2019.134306

Chernick, 2018, High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia., J. Neurochem., 147, 647, 10.1111/jnc.14554

Chew, 2020, Involvement of lipids in Alzheimer’s disease pathology and potential therapies., Front. Physiol., 11, 10.3389/fphys.2020.00598

Chouinard-Watkins, 2013, Disturbance in uniformly 13 C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele., Br. J. Nutr., 110, 1751, 10.1017/s0007114513001268

Christensen, 1992, Renal tubule gp330 is a calcium binding receptor for endocytic uptake of protein., J. Histochem. Cytochem., 40, 1481, 10.1177/40.10.1382088

Corbo, 1999, Apolipoprotein E (APOE) allele distribution in the world. Is APOE∗ 4 a ‘thrifty’allele?, Ann. Hum. Genet., 63, 301, 10.1046/j.1469-1809.1999.6340301.x

Corder, 2004, The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism., Ann. N. Y. Acad. Sci., 1019, 24, 10.1196/annals.1297.005

Cruchaga, 2012, Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer’s disease., Hum. Mol. Genet., 21, 4558, 10.1093/hmg/dds296

Cui, 2011, Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels., Neurochem. Res., 36, 1910, 10.1007/s11064-011-0513-3

DeVos, 2017, Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy., Sci. Transl. Med., 9, 10.1126/scitranslmed.aag0481

Dlugosz, 2018, The reelin receptors apolipoprotein E receptor 2 (ApoER2) and VLDL receptor., Int. J. Mol. Sci., 19, 10.3390/ijms19103090

dos Santos Rodrigues, 2019, ApoE-2 brain-targeted gene therapy through transferrin and penetratin tagged liposomal nanoparticles., Pharm. Res., 36, 10.1007/s11095-019-2691-7

Egert, 2012, ApoE genotype: from geographic distribution to function and responsiveness to dietary factors., Proc. Nutr. Soc., 71, 410, 10.1017/s0029665112000249

Etique, 2013, LRP-1: a checkpoint for the extracellular matrix proteolysis., BioMed Res. Int., 2013, 10.1155/2013/152163

Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis., Jama, 278, 1349, 10.1001/jama.1997.03550160069041

Fernandez, 2019, The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer’s disease., Front. Aging Neurosci., 11, 10.3389/fnagi.2019.00014

Flowers, 2020, APOE in the normal brain., Neurobiol. Dis., 136, 10.1016/j.nbd.2019.104724

Frieden, 2012, Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease., Proc. Natl. Acad. Sci. U.S.A., 109, 8913, 10.1073/pnas.1207022109

Gilat-Frenkel, 2014, Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo., Curr. Alzheimer Res., 11, 549, 10.2174/1567205010666131119232444

Goldstein, 2015, A century of cholesterol and coronaries: from plaques to genes to statins., Cell, 161, 161, 10.1016/j.cell.2015.01.036

Gottschalk, 2016, The role of upregulated APOE in Alzheimer’s disease etiology., J. Alzheimers Dis. Park., 6, 10.4172/2161-0460.1000209

Guptill, 2017, Phase 1 randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of a single escalating dose and repeated doses of CN-105 in healthy adult subjects., J. Clin. Pharmacol., 57, 770, 10.1002/jcph.853

Hara, 2003, Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans., Arterioscler. Thromb. Vasc. Biol., 23, 269, 10.1161/01.atv.0000054199.78458.4b

Hatters, , Apolipoprotein E structure: insights into function., Trends Biochem. Sci., 31, 445, 10.1016/j.tibs.2006.06.008

Hatters, , Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils., J. Mol. Biol., 361, 932, 10.1016/j.jmb.2006.06.080

Hauser, 2011, Apolipoprotein E: from lipid transport to neurobiology., Prog. Lipid Res., 50, 62, 10.1016/j.plipres.2010.09.001

He, 2007, Apolipoprotein receptor 2 and X11α/β mediate apolipoprotein E-induced endocytosis of amyloid-β precursor protein and β-secretase, leading to amyloid-β production., J. Neurosci., 27, 4052, 10.1523/jneurosci.3993-06.2007

Heinsinger, 2016, Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid., J. Neuropathol. Exp. Neurol., 75, 918, 10.1093/jnen/nlw067

Hinrich, 2016, Therapeutic correction of ApoER2 splicing in Alzheimer’s disease mice using antisense oligonucleotides., EMBO Mol. Med., 8, 328, 10.15252/emmm.201505846

Hoe, 2006, Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons., Mol. Neurodegener., 1, 10.1186/1750-1326-1-18

Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease., Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a006312

Hsu, 2019, Sex differences in gene expression patterns associated with the APOE4 allele., F1000Research, 8, 10.12688/f1000research.18671.2

Hu, 2015, Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice., Mol. Neurodegener., 10, 1, 10.1016/j.bbr.2004.09.019

Huang, 2017, ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ secretion., Cell, 168, 427, 10.1016/j.cell.2016.12.044

Huang, 2015, Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation., J. Lipid Res., 56, 215, 10.1194/jlr.m050567

Hubin, 2019, Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation., FEBS Lett., 593, 1144, 10.1002/1873-3468.13428

Hudry, 2013, Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain., Sci. Transl. Med., 5, 10.1126/scitranslmed.3007000

Huynh, 2017, Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of β-amyloidosis., Neuron, 96, 1013, 10.1016/j.neuron.2017.11.014

Ittner, 2019, Adeno-associated virus-based Alzheimer’s disease mouse models and potential new therapeutic avenues., Br. J. Pharmacol., 176, 3649, 10.1111/bph.14637

Kanekiyo, 2013, Neuronal clearance of amyloid-β by endocytic receptor LRP1., J. Neurosci., 33, 19276, 10.1523/jneurosci.3487-13.2013

Kanekiyo, 2012, LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer’s amyloid-β., J. Neurosci., 32, 16458, 10.1523/jneurosci.3987-12.2012

Kanekiyo, 2014, ApoE and Aβ in Alzheimer’s disease: accidental encounters or partners?, Neuron, 81, 740, 10.1016/j.neuron.2014.01.045

Kang, 2018, Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau., J. Exp. Med., 215, 2235, 10.1084/jem.20180653

Kim, 2009, The Role of Apolipoprotein E in Alzheimer’s Disease., Neuron, 63, 287, 10.1016/j.neuron.2009.06.026

Kim, 2012, Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis., J. Exp. Med., 209, 2149, 10.1084/jem.20121274

Kloske, 2020, The important interface between apolipoprotein e and neuroinflammation in Alzheimer’s disease., Front. Immunol., 11, 10.3389/fimmu.2020.00754

Koch, 2001, Characterization of four lipoprotein classes in human cerebrospinal fluid., J. Lipid Res., 42, 1143, 10.1016/s0022-2275(20)31605-9

Kockx, 2008, Regulation of endogenous apolipoprotein E secretion by macrophages., Arterioscler. Thromb. Vasc. Biol., 28, 1060, 10.1161/atvbaha.108.164350

Kounnas, 1994, Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues., Vivo Athens Greece, 8, 343

Krishnamurthy, 2020, ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease., Brain Res., 1733, 10.1016/j.brainres.2020.146685

Lane-Donovan, 2017, The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease., J. Lipid Res., 58, 1036, 10.1194/jlr.r075507

Laskowitz, 2017, Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model., Sci. Rep., 7, 10.1038/srep46461

Liao, 2014, Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis., J. Neurosci., 34, 7281, 10.1523/jneurosci.0646-14.2014

Liao, 2018, Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation., J. Clin. Invest., 128, 2144, 10.1172/jci96429

Lim, 2020, Relationships between plasma lipids species, gender, risk factors, and Alzheimer’s disease., J. Alzheimers Dis., 76, 303, 10.3233/jad-191304

Lin, 2018, APOE4 causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human iPSC-derived brain cell types., Neuron, 98, 1141, 10.1016/j.neuron.2018.05.008

Liu, 2017, Astrocytic LRP1 mediates brain Aβ clearance and impacts amyloid deposition., J. Neurosci., 37, 4023, 10.1523/jneurosci.3442-16.2017

Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy., Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263

Liu, 2018, Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH., Stroke Vasc. Neurol., 3, 222, 10.1136/svn-2018-000152

Liu, 2014, Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer’s disease related amyloid β and tau pathology., J. Neurochem., 128, 577, 10.1111/jnc.12484

Lohner, 2013, Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications., Ann. Nutr. Metab., 62, 98, 10.1159/000345599

Ma, 2018, Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism., Mol. Neurodegener., 13, 1, 10.1186/s13024-018-0286-0

Mahley, 2000, Apolipoprotein E: far more than a lipid transport protein., Annu. Rev. Genomics Hum. Genet., 1, 507, 10.1146/annurev.genom.1.1.507

Marottoli, 2017, Peripheral inflammation, apolipoprotein E4, and amyloid-β interact to induce cognitive and cerebrovascular dysfunction., ASN Neuro, 9, 10.1177/1759091417719201

Marschang, 2004, Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1., Mol. Cell. Biol., 24, 3782, 10.1128/mcb.24.9.3782-3793.2004

Martínez-Morillo, 2014, Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls., Acta Neuropathol. (Berl.), 127, 633, 10.1007/s00401-014-1266-2

McIntosh, 2012, The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)., PLoS One, 7, 10.1371/journal.pone.0047760

Mesa-Herrera, 2019, Lipid and lipid raft alteration in aging and neurodegenerative diseases: a window for the development of new biomarkers., Int. J. Mol. Sci., 20, 10.3390/ijms20153810

Nelson, 2019, Apolipoprotein E particle size is increased in Alzheimer’s disease., Alzheimers Dement. Diagn. Assess. Dis. Monit., 11, 10, 10.1016/j.dadm.2018.10.005

Neu, 2017, Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis., JAMA Neurol., 74, 1178, 10.1001/jamaneurol.2017.2188

Nguyen, 2010, Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4., Biochemistry, 49, 10881, 10.1021/bi1017655

Nickerson, 2000, Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene., Genome Res., 10, 1532, 10.1101/gr.146900

Osei-Hwedieh, 2011, Apolipoprotein mimetic peptides: mechanisms of action as anti-atherogenic agents., Pharmacol. Ther., 130, 83, 10.1016/j.pharmthera.2010.12.003

Palmisano, 2018, Sex differences in lipid and lipoprotein metabolism., Mol. Metab., 15, 45, 10.1016/j.molmet.2018.05.008

Pankiewicz, 2014, Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice., Acta Neuropathol. Commun., 2, 10.1186/s40478-014-0075-0

Payami, 1994, Alzheimer’s disease, apolipoprotein E4, and gender., Jama, 271, 1316, 10.1001/jama.271.17.1316

Peng, 2003, Lipoproteins produced by ApoE–/–astrocytes infected with adenovirus expressing human ApoE., J. Neurochem., 86, 1391, 10.1046/j.1471-4159.2003.01950.x

Phillips, 2014, Apolipoprotein E isoforms and lipoprotein metabolism., IUBMB Life, 66, 616, 10.1002/iub.1314

Prasad, 2018, Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH., Proc. Natl. Acad. Sci. U.S.A., 115, E6640, 10.1073/pnas.1801612115

Qian, 2017, APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts., PLoS Med., 14, 10.1371/journal.pmed.1002254

Qosa, 2012, Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer’s disease., J. Alzheimers Dis., 31, 151, 10.3233/jad-2012-120319

Rapp, 2006, Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes., Biochimie, 88, 473, 10.1016/j.biochi.2005.10.007

Rawat, 2019, ApoE4 alters ABCA1 membrane trafficking in astrocytes., J. Neurosci., 39, 9611, 10.1523/jneurosci.1400-19.2019

Rebeck, 2017, The role of APOE on lipid homeostasis and inflammation in normal brains., J. Lipid Res., 58, 1493, 10.1194/jlr.r075408

Reiman, 2020, Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study., Nat. Commun., 11, 1, 10.1038/s41467-019-14279-8

Riddell, 2008, Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels., J. Neurosci., 28, 11445, 10.1523/jneurosci.1972-08.2008

Ruiz, 2005, The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor., J. Lipid Res., 46, 1721, 10.1194/jlr.m500114-jlr200

Russell, 2009, Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain., Annu. Rev. Biochem., 78, 1017, 10.1146/annurev.biochem.78.072407.103859

Safieh, 2019, ApoE4: an emerging therapeutic target for Alzheimer’s disease., BMC Med., 17, 10.1186/s12916-019-1299-4

Sawmiller, 2019, A novel apolipoprotein E antagonist functionally blocks apolipoprotein E interaction with N-terminal amyloid precursor protein, reduces β-amyloid-associated pathology, and improves cognition., Biol. Psychiatry, 86, 208, 10.1016/j.biopsych.2019.04.026

Schoch, 2017, Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases., Neuron, 94, 1056, 10.1016/j.neuron.2017.04.010

Shi, 2017, ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy., Nature, 549, 523, 10.1038/nature24016

Shinohara, 2010, Reduction of brain β-amyloid (Aβ) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Aβ clearance., J. Biol. Chem., 285, 22091, 10.1074/jbc.m110.102277

Singh, 2006, APOE distribution in world populations with new data from India and the UK., Ann. Hum. Biol., 33, 279, 10.1080/03014460600594513

Singh, 2020, TLR4 (toll-like receptor 4)-dependent signaling drives extracellular catabolism of LDL (low-density lipoprotein) aggregates., Arterioscler. Thromb. Vasc. Biol., 40, 86, 10.1161/atvbaha.119.313200

Solomon, 2018, Effect of the apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial., JAMA Neurol., 75, 462, 10.1001/jamaneurol.2017.4365

Spuch, 2015, Soluble megalin is reduced in cerebrospinal fluid samples of Alzheimer’s disease patients., Front. Cell. Neurosci., 9, 10.3389/fncel.2015.00134

Suidan, 2019, Targeting apolipoprotein E for Alzheimer’s disease: an industry perspective., Int. J. Mol. Sci., 20, 10.3390/ijms20092161

Svennerholm, 1997, Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes., Acta Neuropathol. (Berl.), 94, 345, 10.1007/s004010050717

Tachibana, 2019, APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1., J. Clin. Invest., 129, 1272, 10.1172/jci124853

Tachibana, 2016, Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1., Exp. Neurol., 277, 1, 10.1016/j.expneurol.2015.12.003

Talwar, 2016, Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer’s disease., J. Neurol. Sci., 360, 179, 10.1016/j.jns.2015.12.004

Tarasoff-Conway, 2015, Clearance systems in the brain—implications for Alzheimer disease., Nat. Rev. Neurol., 11, 10.1038/nrneurol.2015.119

Tcw, 2019, Cholesterol and Matrisome Pathways Dysregulated in Human APOE ϵ4 Glia., 10.2139/ssrn.3435267

Teng, 2017, ApoE influences the blood-brain barrier through the NF-κB/MMP-9 pathway after traumatic brain injury., Sci. Rep., 7, 1, 10.1038/s41598-017-06932-3

Theendakara, 2016, Direct Transcriptional Effects of Apolipoprotein E., J. Neurosci., 36, 685, 10.1523/JNEUROSCI.3562-15.2016

Ulrich, 2013, In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis., Mol. Neurodegener., 8, 1, 10.1186/1750-1326-8-13

van Veluw, 2017, Detection, risk factors, and functional consequences of cerebral microinfarcts., Lancet Neurol., 16, 730, 10.1016/s1474-4422(17)30196-5

Vasilevskaya, 2020, Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes., NeuroImage Clin., 26, 10.1016/j.nicl.2020.102212

Villeneuve, 2015, Influence of abdominal obesity on the lipid-lipoprotein profile in apoprotein E2/4 carriers: the effect of an apparent duality., J. Lipids, 2015, 10.1155/2015/742408

Wang, 2018, Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector., Nat. Med., 24, 647, 10.1038/s41591-018-0004-z

Williams, 2020, APOE alters glucose flux through central carbon pathways in astrocytes., Neurobiol. Dis., 136, 10.1016/j.nbd.2020.104742

Wilson, 1991, Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E., Science, 252, 1817, 10.1126/science.2063194

Wolters, 2019, The impact of APOE genotype on survival: results of 38,537 participants from six population-based cohorts (E2-CHARGE)., PLoS One, 14, 10.1371/journal.pone.0219668

Wu, 2018, Human apoe isoforms differentially modulate brain glucose and ketone body metabolism: Implications for Alzheimer’s disease risk reduction and early intervention., J. Neurosci., 38, 6665, 10.1523/JNEUROSCI.2262-17.2018

Yajima, 2015, ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA., Biochem. Biophys. Res. Commun., 456, 482, 10.1016/j.bbrc.2014.11.111

Yamazaki, 2019, Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies., Nat. Rev. Neurol., 15, 501, 10.1038/s41582-019-0228-7

Yang, 2007, Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube., J. Biotechnol., 131, 106, 10.1016/j.jbiotec.2007.06.001

Yao, 2012, Apolipoprotein mimetic peptides: a new approach for the treatment of asthma., Front. Pharmacol., 3, 10.3389/fphar.2012.00037

Yassine, 2016, ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and alzheimer’s disease., J. Am. Heart Assoc., 5, 10.1161/JAHA.115.002886

Yassine, 2020, APOE alleles and diet in brain aging and Alzheimer’s disease., Front. Aging Neurosci., 12, 10.3389/fnagi.2020.00150

Yu, 2014, Apolipoprotein E in Alzheimer’s disease: an update., Annu. Rev. Neurosci., 37, 79, 10.1093/jnen/59.9.751

Zhao, 2017, APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes., Hum. Mol. Genet., 26, 2690, 10.1093/hmg/ddx155

Zhao, 2016, Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer’s disease mouse models., Neurobiol. Aging, 44, 159, 10.1016/j.neurobiolaging.2016.04.020

Zhao, , Apolipoprotein E, receptors, and modulation of Alzheimer’s disease., Biol. Psychiatry, 83, 347, 10.1016/j.biopsych.2017.03.003

Zhao, , APOE ε2 is associated with increased tau pathology in primary tauopathy., Nat. Commun., 9, 1, 10.1038/s41467-018-06783-0

Zhao, 2017, Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes., Neuron, 96, 115, 10.1016/j.neuron.2017.09.003